Quantitative assessment of the central versus peripheral effect of intravenous clonidine using baroreflex equilibrium diagrams

J Physiol Sci. 2021 Dec 31;71(1):39. doi: 10.1186/s12576-021-00824-y.

Abstract

Clonidine is a first-generation central antihypertensive that reduces sympathetic nerve activity (SNA). Although clonidine also exerts peripheral vasoconstriction, the extent to which this vasoconstriction offsets the centrally mediated arterial pressure (AP)-lowering effect remains unknown. In anesthetized rats (n = 8), we examined SNA and AP responses to stepwise changes in carotid sinus pressure under control conditions and after intravenous low-dose (2 μg/kg) and high-dose clonidine (5 μg/kg). In the baroreflex equilibrium diagram analysis, the operating-point AP under the control condition was 115.2 (108.5-127.7) mmHg [median (25th-75th percentile range)]. While the operating-point AP after low-dose clonidine was not significantly different with or without the peripheral effect, the operating-point AP after high-dose clonidine was higher with the peripheral effect than without [81.3 (76.2-98.2) mmHg vs. 70.7 (57.7-96.9), P < 0.05]. The vasoconstrictive effect of clonidine partly offset the centrally mediated AP-lowering effect after high-dose administration.

Keywords: Baroreflex equilibrium diagram; Carotid sinus baroreflex; Clonidine; Open-loop systems analysis; Rats.

MeSH terms

  • Animals
  • Antihypertensive Agents / pharmacology
  • Baroreflex*
  • Blood Pressure
  • Carotid Sinus
  • Clonidine* / pharmacology
  • Rats
  • Sympathetic Nervous System

Substances

  • Antihypertensive Agents
  • Clonidine